a drug used for more than a decade to treat psoriasis is preventing and halting the rejection of transplanted organs in animals a stanford university researcher said the compound will be tested on human transplant patients pending approval by the us food and drug administration said dr randall morris director of stanfords laboratory for transplant immunology the drug mycophenolic acid inhibits the formation of dna critical in the growth of skin lesions common to psoriasis researchers altered mycophenolic acid to make it more easily absorbed by the body in its altered form it defuses the dna process required for white blood cells to attack transplanted organs morris said